Clinical Trial Update: Development of an Innovative Hemodialysis Method to Improve Dialytic Clearance of Protein-bound Uremic Toxins [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating an innovative hemodialysis method to improve clearance of protein-bound uremic toxins; the study is currently not yet recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Hemolytic Anemia

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: End Stage Renal Disease, Chronic Hemolysis | Phase 2 | Status: NOT_YET_RECRUITING